Explore comprehensive CDMO, CMO and CPO services offered by Eirgen Pharma, supporting end-to-end Anlaytical Testing, Drug Development, Manufacturing and Packaging. Eirgen Pharma enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Ireland, U.S.A., United Kingdom
Description: EirGen Pharma is an Irish pharmaceutical company specializing in the development and manufacturing of high-potency oral solid dose (OSD) products, including those for oncology, for human and veterinary use. Founded in 2005, it was acquired by OPKO Health in 2015 and now offers services as a contract development and manufacturing organization (CDMO). EirGen Pharma has regulatory approvals from the US FDA, European Medicines Agency (EMA), and others, and serves global markets including the US, EU, Japan, and the Middle East.
